PFIZER Company Profile

✉ Email this page to a colleague

▶ Start for $1
Remove trial restrictions

PFIZER has one hundred and eighty-nine approved drugs.

There are thirty-seven US patents protecting PFIZER drugs. There is one tentative approval on PFIZER drugs.

There are seven hundred and fifty-seven patent family members on PFIZER drugs in sixty-six countries and two hundred and forty-two supplementary protection certificates in nineteen countries.

International Patents:	757
US Patents:	37
Tradenames:	154
Ingredients:	125
NDAs:	189
Drug Master File Entries:	3
Patent Litigation for PFIZER:	See patent lawsuits for PFIZER
PTAB Cases with PFIZER as petitioner:	See PTAB cases with PFIZER as petitioner

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	CLEOCIN PHOSPHATE	clindamycin phosphate	INJECTABLE;INJECTION	062803-001	Oct 16, 1987	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Pfizer	CYTOTEC	misoprostol	TABLET;ORAL	019268-001	Dec 27, 1988	AB	RX	Yes	Yes		See Plans and Pricing				See Plans and Pricing
Pfizer	TESSALON	benzonatate	CAPSULE;ORAL	011210-001	Approved Prior to Jan 1, 1982	AA	RX	Yes	No		See Plans and Pricing				See Plans and Pricing
Pfizer	CALAN	verapamil hydrochloride	TABLET;ORAL	018817-002	Sep 10, 1984		DISCN	Yes	No		See Plans and Pricing				See Plans and Pricing
Pfizer	CEFOBID	cefoperazone sodium	INJECTABLE;INJECTION	063333-002	Mar 31, 1995		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Pfizer	DEPO-MEDROL	methylprednisolone acetate	INJECTABLE;INJECTION	011757-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	No		See Plans and Pricing				See Plans and Pricing
Pfizer	ATARAX	hydroxyzine hydrochloride	TABLET;ORAL	010392-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	DEPO-PROVERA	medroxyprogesterone acetate	INJECTABLE;INJECTION	012541-003	Approved Prior to Jan 1, 1982	4,038,389	See Plans and Pricing
Pfizer	MICRONASE	glyburide	TABLET;ORAL	017498-003	May 1, 1984	3,426,067	See Plans and Pricing
Pfizer	ZYVOX	linezolid	SOLUTION;INTRAVENOUS	021131-001	Apr 18, 2000	6,559,305*PED	See Plans and Pricing
Pfizer Pharms	REZULIN	troglitazone	TABLET;ORAL	020720-001	Jan 29, 1997	5,859,037	See Plans and Pricing
Pfizer	COVERA-HS	verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	020552-002	Feb 26, 1996	4,612,008	See Plans and Pricing
Pfizer	TIKOSYN	dofetilide	CAPSULE;ORAL	020931-003	Oct 1, 1999	6,124,363	See Plans and Pricing
Pfizer	MINIZIDE	polythiazide; prazosin hydrochloride	CAPSULE;ORAL	017986-003	Approved Prior to Jan 1, 1982	3,511,836	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	5 mg and 10 mg	➤ Subscribe	2005-06-21
➤ Subscribe	For Injection	500 mg/vial	➤ Subscribe	2011-06-17
➤ Subscribe	Oral Suspension	100 mg/5 mL	➤ Subscribe	2009-08-03
➤ Subscribe	Injection	2 mg/mL, 100 mL bag	➤ Subscribe	2009-12-29
➤ Subscribe	Tablets	5 mg	➤ Subscribe	2016-11-07
➤ Subscribe	Delayed-release Tablets	50 mg/0.2 mg	➤ Subscribe	2009-06-29
➤ Subscribe	Extended-release Tablets	11 mg	➤ Subscribe	2016-11-07
➤ Subscribe	Capsules	20 mg, 40 mg, 60 mg and 80 mg	➤ Subscribe	2005-02-07
➤ Subscribe	Capsules	75 mg, 100 mg and 125 mg	➤ Subscribe	2019-02-04
➤ Subscribe	Capsules	0.125 mg, 0.25 mg, and 0.5 mg	➤ Subscribe	2014-05-01
➤ Subscribe	Tablets	600 mg	➤ Subscribe	2005-12-21
➤ Subscribe	Injection	2 mg/mL, 300 mL bag	➤ Subscribe	2009-09-01
➤ Subscribe	Tablets	1 g	➤ Subscribe	2005-08-23
➤ Subscribe	Delayed-release Tablets	75 mg/0.2 mg	➤ Subscribe	2008-11-28
➤ Subscribe	Extended-release Tablets	4 mg and 8 mg	➤ Subscribe	2012-10-31
➤ Subscribe	Injection	20 mg/mL, 2 mL and 5 mL vials	➤ Subscribe	2004-07-26

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1470124	333 9-2017	Slovakia	See Plans and Pricing	PRODUCT NAME: PALBOCIKLIB; REGISTRATION NO/DATE: EU/1/16/1147 20161111
1380301	2009C/007	Belgium	See Plans and Pricing	PRODUCT NAME: DROSPIRENONE-ETHINYLESTRADIOL; AUTHORISATION NUMBER AND DATE: BE321386 20080811
2767537	2019C/551	Belgium	See Plans and Pricing	PRODUCT NAME: TALAZOPARIB, OPTIONEEL IN DE VORM VAN EEN FARMACEUTISCH ZOUT; AUTHORISATION NUMBER AND DATE: EU/1/19/1377 20190624
2170860	301057	Netherlands	See Plans and Pricing	PRODUCT NAME: GLASDEGIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, MET INBEGRIP VAN HET MALEAATZOUT; REGISTRATION NO/DATE: EU/1/20/1451/001-004 20200626
2767537	408 19-2019	Slovakia	See Plans and Pricing	OWNER(S): MEDIVATION TECHNOLOGIES LLC, NEW YORK, NY, US; DATUM ZAPISU DO REGISTRA: 20.1.2022
0565634	06C0030	France	See Plans and Pricing	PRODUCT NAME: EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 32075 20060623; FIRST REGISTRATION: LI - 55783 01 20020607
0208846	C990021	Netherlands	See Plans and Pricing	PRODUCT NAME: ZALEPLONUM; REGISTRATION NO/DATE: EU/1/99/099/001 - EU/1/99/099/006, EU/1/99/102/001 - EU/1/99/102/006 19990312
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.